APLLTD — Alembic Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Alembic Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	2,850	611	755	1,202	950
Net Total Accounts Receivable
Net Total Receivables	7,220	10,687	12,338	11,861	14,108
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	26,520	28,608	29,100	30,786	40,878
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	36,472	39,473	29,997	30,711	33,608
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	67,090	71,220	61,828	64,456	77,729
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,808	17,165	16,369	14,550	24,123
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	16,420	18,845	18,124	16,274	25,820
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	50,670	52,376	43,705	48,182	51,909
Total Liabilities & Shareholders' Equity	67,090	71,220	61,828	64,456	77,729
Total Common Shares Outstanding